Deciphera Pharmaceuticals, Llc

This study is testing whether an experimental drug called vimseltinib is safe and effective for adults with moderate to severe chronic graft-versus-host disease (cGVHD) who haven't improved with at least two previous treatments. Participants will take the drug in 28-day cycles fo…

This study is testing a new drug, DCC-3116, in combination with other approved cancer therapies for people with advanced GIST, a type of stomach cancer. The main goals are to find the safest and most effective dose of the drug combination and to see if it helps shrink tumors. It …

This is the first study in people for a new oral drug called DCC-2812. It aims to find a safe dose and see if it can help control advanced kidney, bladder, or prostate cancer that has spread. The study will enroll about 60 people to check for side effects and see if the drug show…

This study is testing whether a new drug called DCC-3009 is safe and effective for treating advanced gastrointestinal stromal tumors (GIST), a type of cancer in the digestive system. It will enroll about 120 adults whose cancer has continued to grow despite standard treatments. T…

This study aims to learn how patients with a rare, non-cancerous joint tumor (TGCT) use the drug vimseltinib in everyday medical practice. It will observe about 100 patients who are already prescribed this medication to see how long they stay on treatment and how it affects their…